CHOP/ORP150 ratio in endoplasmic reticulum stress: A new mechanism for diabetic peripheral neuropathy

Cellular Physiology and Biochemistry

Volumn 32, Issue 2, 2013, Pages 367-379

  Wu, Yuan Bo ^a   Li, Hong Qi ^a   Ren, Ming Shan ^a   Li, Wen Ting ^a   Lv, Xin Yi ^a   Wang, Li ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; CHOP; Diabetic peripheral neuropathy (DPN); ER stress; ORP150; Reactive oxygen species (ROS); Schwann cells (SCs); Type II diabetes mellitus

Indexed keywords

GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEMOGLOBIN A1C; HYDROGEN PEROXIDE; OXYGEN REGULATED PROTEIN 150; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE DURATION; ENDOPLASMIC RETICULUM STRESS; EPIDIDYMIS FAT; FAT MASS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MALE; MOTOR NERVE CONDUCTION; NERVE CELL; NERVE FIBER; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL CULTURE; SCIATIC NERVE; SENSORY NERVE CONDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

RATTUS;

ANIMALS; BLOTTING, WESTERN; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; GLUCOSE TOLERANCE TEST; HSP70 HEAT-SHOCK PROTEINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR CHOP;

EID: 84885673980     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354444     Document Type: Article

References (46)

1. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154.
2. Vincent AM, Feldman EL: New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord 2004;5:227-236.
3. Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Annals of Neurology 1986;19:450-457.
4. Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, Hsieh ST: Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004;127:1593-1605.
5. Said G: Diabetic neuropathy-a review. Nat Clin Pract Neurol 2007;3:331-340.
6. Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F 3rd, Feldman EL: Mouse models of diabetic neuropathy. Neurobiol Dis 2007;28:276-285.
7. Chisholm DJ: The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management. Med J Aust 1993;159:721-723.
8. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
9. Tomlinson DR, Gardiner NJ: Glucose neurotoxicity. Nat Rev Neurosci 2008;9:36-45.
10. Lupachyk S, Watcho P, Stavniichuk R, Shevalye H, Obrosova IG: Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes 2013;62:944-52.
11. Cameron NE: Role of endoplasmic reticulum stress in diabetic neuropathy. Diabetes 2013;62:696-697.
12. Li L, Ye XP, Lu AZ, Zhou SQ, Liu H, Liu ZJ, Jiang S, Xu SY: Hyperglycemia magnifies bupivacaine-induced cell apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress. J Neurosci Res 2013;91:786-798.
13. Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 1992;6:439-453.
14. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D: CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev 1994;8:453-464.
15. Gotoh T, Oyadomari S Mori K, Mori M: Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 2002;277:12343-12350.
16. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998;12:982-995.
17. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002;109:525-532.
18. Oyadomari S, Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381-389.
19. Gow A, Wrabetz L: CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol. 2009;19:505-510.
20. Kitao Y, Ozawa K, Miyazaki M, Tamatani M, Kobayashi T, Yanagi H, Okabe M, Ikawa M, Yamashima T, Stern DM, Hori O, Ogawa S: Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity. J Clin Invest 2001;108:1439-1450.
21. Tamatani M, Matsuyama T, Yamaguchi A, Mitsuda N, Tsukamoto Y, Taniguchi M, Che YH, Ozawa K, Hori O, Nishimura H, Yamashita A, Okabe M, Yanagi H, Stern DM, Ogawa S, Tohyama M: ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med 2001;7:317-323.
22. Miyazaki M, Ozawa K, Hori O, Kitao Y, Matsushita K, Ogawa S, Matsuyama T: Expression of 150-kd oxygenregulated protein in the hippocampus suppresses delayed neuronal cell death. J Cereb Blood Flow Metab 2002;22:979-987.
23. Kitano H, Nishimura H, Tachibana H, Yoshikawa H, Matsuyama T: ORP150 ameliorates ischemia/ reperfusion injury from middle cerebral artery occlusion in mouse brain. Brain Res 2004;1015:122-128.
24. Kusaczuk M, Cechowska-Pasko M: Molecular Chaperone ORP150 in ER Stress-related Diseases. Curr Pharm Des 2013;19:2807-2818.
25. Coppey LJ, Holmes A, Davidson EP, Yorek MA: Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. J Nutr Metab 2012;2012:950517.
26. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA: Attenuation of Vascular/Neural Dysfunction in Zucker Rats Treated with Enalapril or Rosuvastatin. Obesity 2008;16:82-89.
27. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjati K, Pacher P, Szabo C, Stevens MJ: Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004;53:711-720.
28. Brockes JP, Fields KL, Raff MC: Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 1979;165:105-118.
29. Elmén J, Thonberg H, Ljungberg K, Frieden M, Westergaard M, Xu Y, Wahren B, Liang Z, Ørum H, Koch T, Wahlestedt C: Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res 2005;33:439-447.
30. Han H, Wang H, Long H, Nattel S, Wang Z: Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 2001;276:26357-26364.
31. Zhou J-Y, Zhou S-W: Protection of trigonelline on experimental diabetic peripheral neuropathy. Evid Based Complement Alternat Med 2012;2012:164219.
32. Kallenborn-Gerhardt W, Schröder K, Del Turco D, Lu R, Kynast K, Kosowski J, Niederberger E, Shah AM, Brandes RP, Geisslinger G, Schmidtko A: NADPH oxidase-4 maintains neuropathic pain after peripheral nerve injury. J Neurosci 2012;32:10136-10145.
33. Rhee SG, Chang TS, Jeong W, Kang D: Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol Cells 2010;29:539-549.
34. Ni M, Lee AS: ER chaperones in mammalian development and human diseases. FEBS Lett 2007;581:3641-3651.
35. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M: Induction of neuronal death by ER stress in Alzheimer's disease. J Chem Neuroanat 2004;28:67-78.
36. Kim R, Emi M, Tanabe K, Murakami S: Role of the unfolded protein response in cell death. Apoptosis 2006;11:5-13.
37. Shin YK, Jang SY, Lee HK, Jung J, Suh DJ, Seo SY, Park HT: Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-inducedperipheral neuropathy. Glia 2010;58:1961-1976.
38. Thacker MA, Clark AK, Marchand F, McMahon SB: Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007;105:838-847.
39. Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, Niwa M, Aoki J, Chun J, Ueda H: Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain 2010;6:78. doi: 10.1186/1744-8069-6-78.
40. Devor M: Centralization, central sensitization and neuropathic pain. Focus on "sciatic chronic constrictioninjury produces cell-type-specific changes in the electrophysiological properties of rat substantia gelatinosa neurons". J Neurophysiol 2006;96:522-523.
41. Askwith T, Zeng W, Eggo MC, Stevens MJ: Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells. Exp Neurol 2012;233:154-162.
42. Vincent AM, Callaghan BC, Smith AL, Feldman EL: Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011;7:573-583.
43. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000;49:1390-1394.
44. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P: Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-320.
45. Davidson EP, Coppey LJ, Holmes A, Dake B, Yorek MA: Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. European J Pharmacol 2011;688:497-506.
46. Tabas I, Ron D: Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011;13:184-190.